{"id":52265,"date":"2025-10-15T02:31:24","date_gmt":"2025-10-14T21:01:24","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/"},"modified":"2025-10-15T02:31:24","modified_gmt":"2025-10-14T21:01:24","slug":"cse-bulletin-new-listing-tempramed-technologies-ltd-vivi","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/","title":{"rendered":"CSE Bulletin: New Listing – TempraMed Technologies Ltd. (VIVI)"},"content":{"rendered":"

<\/p>\n

Toronto, Ontario–(Newsfile Corp. –\u00a0Le 14 octobre\/October 2025) – The common shares of TempraMed Technologies Ltd. have been approved for listing on the CSE.<\/p>\n

Listing and disclosure documents will be available at www.thecse.com<\/a> on the trading date. <\/p>\n

TempraMed develops patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed\u2019s primary business focus is revolutionizing injectors for temperature-sensitive medications by making them “SMART” and temperature-protected. <\/p>\n

_________________________________ <\/p>\n

Les actions ordinaires de TempraMed Technologies Ltd. ont \u00e9t\u00e9 approuv\u00e9es pour inscription au CSE. <\/p>\n

Les documents de cotation et d’information seront disponibles sur www.thecse.com<\/a> \u00e0 la date de n\u00e9gociation. <\/p>\n

TempraMed d\u00e9veloppe une technologie prot\u00e9g\u00e9e par des brevets, con\u00e7ue pour servir une large gamme de produits m\u00e9dicaux et grand public. L’activit\u00e9 principale de TempraMed consiste \u00e0 r\u00e9volutionner les injecteurs pour les m\u00e9dicaments sensibles \u00e0 la temp\u00e9rature en les rendant “INTELLIGENTS” et prot\u00e9g\u00e9s contre les variations de temp\u00e9rature. <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Issuer\/\u00c9metteur : <\/td>\n\n

TempraMed Technologies Ltd. <\/p>\n<\/td>\n<\/tr>\n

Security Type\/Titre : <\/td>\n Common Shares\/Actions ordinaires <\/td>\n<\/tr>\n
Symbol(s)\/Symbole(s) : <\/td>\n VIVI <\/td>\n<\/tr>\n
NV Issuer\/\u00c9metteur non \u00c9mergent : <\/td>\n No\/Non <\/td>\n<\/tr>\n
Number of securities issued and outstanding\/ Titres \u00e9mis et en circulation : <\/td>\n 73 435 348 <\/td>\n<\/tr>\n
Number of Securities reserved for issuance\/ Titres r\u00e9serv\u00e9s pour \u00e9mission : <\/td>\n 31 500 505 <\/td>\n<\/tr>\n
CSE Sector\/Cat\u00e9gorie : <\/td>\n Life Sciences\/Sciences biologiques <\/td>\n<\/tr>\n
CUSIP : <\/td>\n 88024B 10 2 <\/td>\n<\/tr>\n
ISIN : <\/td>\n CA88024B 10 2 2 <\/td>\n<\/tr>\n
Boardlot\/Quotit\u00e9 : <\/td>\n 500 <\/td>\n<\/tr>\n
Trading Currency\/Monnaie de n\u00e9gociation : <\/td>\n CDN$\/$CDN <\/td>\n<\/tr>\n
Listing Date\/Date de l\u2019inscription : <\/td>\n Le 15 OCT 2025 <\/td>\n<\/tr>\n
Other Exchanges\/Autres marches : <\/td>\n N\/A <\/td>\n<\/tr>\n
Fiscal Year end \/Cl\u00f4ture de l’exercice financier : <\/td>\nLe 31 d\u00e9cembre\/December <\/td>\n<\/tr>\n
Transfer Agent\/Agent des transferts : <\/td>\n Endeavor Trust Corporation <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0
The Exchange is accepting Market Maker applications for VIVI. Please email: Trading@theCSE.com<\/a>. <\/p>\n

\n

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com<\/a>. <\/p>\n

Pour toute question, pour obtenir de l\u2019information suppl\u00e9mentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel \u00e0 l\u2019adresse: Listings@thecse.com<\/a>. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Toronto, Ontario–(Newsfile Corp. –\u00a0Le 14 octobre\/October 2025) – The common shares of TempraMed Technologies Ltd. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. TempraMed develops patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed\u2019s primary business focus …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130],"tags":[],"class_list":["post-52265","post","type-post","status-publish","format-standard","","category-international"],"yoast_head":"\nCSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Toronto, Ontario–(Newsfile Corp. –\u00a0Le 14 octobre\/October 2025) – The common shares of TempraMed Technologies Ltd. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. TempraMed develops patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed\u2019s primary business focus …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T21:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/api.newsfilecorp.com\/newsinfo\/270427\/511\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/\",\"name\":\"CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2025-10-14T21:01:24+00:00\",\"dateModified\":\"2025-10-14T21:01:24+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CSE Bulletin: New Listing – TempraMed Technologies Ltd. (VIVI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/","og_locale":"en_US","og_type":"article","og_title":"CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English","og_description":"Toronto, Ontario–(Newsfile Corp. –\u00a0Le 14 octobre\/October 2025) – The common shares of TempraMed Technologies Ltd. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. TempraMed develops patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed\u2019s primary business focus …","og_url":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2025-10-14T21:01:24+00:00","og_image":[{"url":"https:\/\/api.newsfilecorp.com\/newsinfo\/270427\/511"}],"author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/","url":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/","name":"CSE Bulletin: New Listing - TempraMed Technologies Ltd. (VIVI) - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2025-10-14T21:01:24+00:00","dateModified":"2025-10-14T21:01:24+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/10\/15\/cse-bulletin-new-listing-tempramed-technologies-ltd-vivi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"CSE Bulletin: New Listing – TempraMed Technologies Ltd. (VIVI)"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/52265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=52265"}],"version-history":[{"count":0,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/52265\/revisions"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=52265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=52265"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=52265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}